Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis

Journal of Hepatology

Volumn 53, Issue 1, 2010, Pages 162-169

  Corpechot, Christophe ^a,b   Chrétien, Yves ^a,b   Chazouillères, Olivier ^a,b   Poupon, Raoul ^a,b  

^a HÔPITAL SAINT ANTOINE   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

Author keywords

Autoimmunity; Familial history; Primary biliary cirrhosis; Risk factor; Smoking

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; ANXIOLYTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; COLCHICINE; COLECALCIFEROL; COLESTYRAMINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; LEVOTHYROXINE; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT; RIFAMPICIN; STOMACH SECRETION INHIBITOR; URSODEOXYCHOLIC ACID;

ABORTION; ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FAMILY; FAMILY HISTORY; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; ORAL CONTRACEPTION; PASSIVE SMOKING; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; QUESTIONNAIRE; RAYNAUD PHENOMENON; RECURRENT INFECTION; RELATIVE; REPRODUCTIVE HISTORY; RISK FACTOR; SEX DIFFERENCE; SJOEGREN SYNDROME; SMOKING; URINARY TRACT INFECTION; VACCINATION; AGED; CONFIDENCE INTERVAL; FRANCE; GENETICS; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREGNANCY; RISK;

AGED; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FRANCE; HUMANS; LIFE STYLE; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREGNANCY; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 77953284855     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.02.019     Document Type: Article

References (39)

1. Gershwin M.E., and Mackay I.R. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 47 (2008) 737-745
2. Selmi C., Mayo M.J., Bach N., Ishibashi H., Invernizzi P., Gish R.G., et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127 (2004) 485-492
3. Bach N., and Schaffner F. Familial primary biliary cirrhosis. J Hepatol 20 (1994) 698-701
4. Hirschfield G.M., Liu X., Xu C., Lu Y., Xie G., Gu X., et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 360 (2009) 2544-2555
5. Poupon R., Ping C., Chretien Y., Corpechot C., Chazouilleres O., Simon T., et al. Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J Hepatol 49 (2008) 1038-1045
6. McNally R.J., Ducker S., and James O.F. Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from space-time clustering analysis. Hepatology 50 (2009) 1169-1174
7. Prince M.I., and James O.F. The epidemiology of primary biliary cirrhosis. Clin Liver Dis 7 (2003) 795-819
8. Ala A., Stanca C.M., Bu-Ghanim M., Ahmado I., Branch A.D., Schiano T.D., et al. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology 43 (2006) 525-531
9. Burroughs A.K., Rosenstein I.J., Epstein O., Hamilton-Miller J.M., Brumfitt W., and Sherlock S. Bacteriuria and primary biliary cirrhosis. Gut 25 (1984) 133-137
10. Xu L., Shen Z., Guo L., Fodera B., Keogh A., Joplin R., et al. Does a betaretrovirus infection trigger primary biliary cirrhosis?. Proc Natl Acad Sci USA 100 (2003) 8454-8459
11. Selmi C., Balkwill D.L., Invernizzi P., Ansari A.A., Coppel R.L., Podda M., et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38 (2003) 1250-1257
12. Amano K., Leung P.S., Rieger R., Quan C., Wang X., Marik J., et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 174 (2005) 5874-5883
13. Parikh-Patel A., Gold E.B., Worman H., Krivy K.E., and Gershwin M.E. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States. Hepatology 33 (2001) 16-21
14. Gershwin M.E., Selmi C., Worman H.J., Gold E.B., Watnik M., Utts J., et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42 (2005) 1194-1202
15. James O., Ducker S., and Prince M. Case control studies support the association of environmental and genetic risk factors with primary biliary cirrhosis. Hepatology 42 Suppl. 1 (2005) 209A
16. Parikh-Patel A., Gold E., Utts J., and Gershwin M.E. The association between gravidity and primary biliary cirrhosis. Ann Epidemiol 12 (2002) 264-272
17. Pares A., and Guanabens N. Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment. Clin Liver Dis 12 (2008) 407-424 x
18. Thomas C., Pellicciari R., Pruzanski M., Auwerx J., and Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 7 (2008) 678-693
19. Hardy C.J., Palmer B.P., Muir K.R., Sutton A.J., and Powell R.J. Smoking history, alcohol consumption, and systemic lupus erythematosus: a case-control study. Ann Rheum Dis 57 (1998) 451-455
20. Heliovaara M., Aho K., Aromaa A., Knekt P., and Reunanen A. Smoking and risk of rheumatoid arthritis. J Rheumatol 20 (1993) 1830-1835
21. Prummel M.F., and Wiersinga W.M. Smoking and risk of Graves' disease. JAMA 269 (1993) 479-482
22. Zein C.O., Beatty K., Post A.B., Logan L., Debanne S., and McCullough A.J. Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: a cross validated retrospective assessment. Hepatology 44 (2006) 1564-1571
23. Csepregi A., Szodoray P., and Zeher M. Do autoantibodies predict autoimmune liver disease in primary Sjogren's syndrome? Data of 180 patients upon a 5 year follow-up. Scand J Immunol 56 (2002) 623-629
24. Van de Water J., Turchany J., Leung P.S., Lake J., Munoz S., Surh C.D., et al. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest 91 (1993) 2653-2664
25. Longo M., Crosignani A., Battezzati P.M., Squarcia Giussani C., Invernizzi P., Zuin M., et al. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut 51 (2002) 265-269
26. Solaymani-Dodaran M., Aithal G.P., Card T., and West J. Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: a population-based cohort study. Am J Gastroenterol 103 (2008) 2784-2788
27. Allocca M., Crosignani A., Gritti A., Ghilardi G., Gobatti D., Caruso D., et al. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut 55 (2006) 1795-1800
28. Dudnik L.B., Azyzova O.A., Solovyova N.P., Savchenkova A.P., and Pokrovskaya M.A. Primary biliary cirrhosis and coronary atherosclerosis: protective antioxidant effect of bilirubin. Bull Exp Biol Med 145 (2008) 18-22
29. Su T.C., Hwang J.J., and Kao J.H. Hypercholesterolemia in primary biliary cirrhosis. N Engl J Med 357 (2007) 1561-1562
30. Floreani A., Variola A., Niro G., Premoli A., Baldo V., Gambino R., et al. Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis. Am J Gastroenterol 103 (2008) 1959-1965
31. Pares A., Grande L., Bruix J., Pera C., and Rodes J. Esophageal dysfunction in primary biliary cirrhosis. J Hepatol 7 (1988) 362-367
32. Poupon R.E., Balkau B., Eschwege E., and Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 324 (1991) 1548-1554
33. Lazaridis K.N., Juran B.D., Boe G.M., Slusser J.P., de Andrade M., Homburger H.A., et al. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology 46 (2007) 785-792
34. Brind A.M., Bray G.P., Portmann B.C., and Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut 36 (1995) 615-617
35. Floreani A., Naccarato R., and Chiaramonte M. Prevalence of familial disease in primary biliary cirrhosis in Italy. J Hepatol 26 (1997) 737-738
36. Jones D.E., Watt F.E., Metcalf J.V., Bassendine M.F., and James O.F. Familial primary biliary cirrhosis reassessed: a geographically-based population study. J Hepatol 30 (1999) 402-407
37. Alvaro D., Invernizzi P., Onori P., Franchitto A., De Santis A., Crosignani A., et al. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol 41 (2004) 905-912
38. Alvaro D., Onori P., Metalli V.D., Svegliati-Baroni G., Folli F., Franchitto A., et al. Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology 36 (2002) 297-304
39. Stellon A.J., and Williams R. Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis. Br Med J (Clin Res Ed) 293 (1986) 297-298